Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul H Edelstein

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Archives of Dermatology|April 13, 2011
Antibiotics, acne, and Staphylococcus aureus colonizationMatthew Fanelli, Eli Kupperman, Ebbing Lautenbach, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) eraZhenying Liu, Irving Nachamkin, Paul H Edelstein, et al.
Journal of Clinical Microbiology|July 10, 2009
Prevalence of CTX-M beta-lactamases in Philadelphia, PennsylvaniaShannon E McGettigan, Baofeng Hu, Kathleen Andreacchio, et al.
Infection Control and Hospital Epidemiology|May 25, 2002
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalenceGregory Bisson, Neil O Fishman, Jean Baldus Patel, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|October 3, 2009
Fluoroquinolone-resistant Pseudomonas aeruginosa in chronic rhinosinusitisJoel Guss, W M Abuzeid, Laurel Doghramji, et al.
Infection Control and Hospital Epidemiology|October 29, 2009
Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniaeLeanne B Gasink, Paul H Edelstein, Ebbing Lautenbach, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2012
Risk factors for infection or colonization with CTX-M extended-spectrum-β-lactamase-positive Escherichia coliJennifer H Han, Kei Kasahara, Paul H Edelstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Gr-1high polymorphonuclear leukocytes and NK cells act via IL-15 to clear intracellular Haemophilus influenzae in experimental murine peritonitis and pneumoniaShuichi Miyazaki, Fumio Ishikawa, Kayo Shimizu, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2012
Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremiaJennifer H Han, Kara B Mascitti, Paul H Edelstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapyEbbing Lautenbach, Joshua P Metlay, Warren B Bilker, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Archives of Dermatology|April 13, 2011
Antibiotics, acne, and Staphylococcus aureus colonizationMatthew Fanelli, Eli Kupperman, Ebbing Lautenbach, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) eraZhenying Liu, Irving Nachamkin, Paul H Edelstein, et al.
Journal of Clinical Microbiology|July 10, 2009
Prevalence of CTX-M beta-lactamases in Philadelphia, PennsylvaniaShannon E McGettigan, Baofeng Hu, Kathleen Andreacchio, et al.
Infection Control and Hospital Epidemiology|May 25, 2002
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalenceGregory Bisson, Neil O Fishman, Jean Baldus Patel, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|October 3, 2009
Fluoroquinolone-resistant Pseudomonas aeruginosa in chronic rhinosinusitisJoel Guss, W M Abuzeid, Laurel Doghramji, et al.
Infection Control and Hospital Epidemiology|October 29, 2009
Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniaeLeanne B Gasink, Paul H Edelstein, Ebbing Lautenbach, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2012
Risk factors for infection or colonization with CTX-M extended-spectrum-β-lactamase-positive Escherichia coliJennifer H Han, Kei Kasahara, Paul H Edelstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Gr-1high polymorphonuclear leukocytes and NK cells act via IL-15 to clear intracellular Haemophilus influenzae in experimental murine peritonitis and pneumoniaShuichi Miyazaki, Fumio Ishikawa, Kayo Shimizu, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2012
Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremiaJennifer H Han, Kara B Mascitti, Paul H Edelstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapyEbbing Lautenbach, Joshua P Metlay, Warren B Bilker, et al.
Pageof 8